BioAge Labs BIOA
NASDAQ BIOA
$6.61 -0.20 (-2.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioAge Labs (BIOA) Return on Assets [ROA] (2024 - 2026)

Updated

BioAge Labs' Return on Assets [ROA] came in at -23.63% for Q2 2026, up 0.16 percentage points from -23.79% a year earlier and up 2.23 percentage points from the prior quarter.

Analysis

BioAge Labs (BIOA) Return on Assets [ROA] (2024 - 2026) Analysis & Trends

For FY2025, BioAge Labs' Return on Assets [ROA] was -24.62%, up 12.31 percentage points from FY2024.

  • Going back by year, Return on Assets [ROA] was -36.93% in FY2024.
  • The Q2 2026 figure represents the highest quarterly Return on Assets [ROA] since Q1 2025.
  • Business Quant data shows BIOA's Return on Assets [ROA] at -25.86% (Q1 2026), -26.80% (Q4 2025) and -24.31% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 BioAge Labs 302.59 Mn 302.59 Mn -14.23 Mn -23.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.63%
Mar 31, 2026 -25.86%
Dec 31, 2025 -26.80%
Sep 30, 2025 -24.31%
Jun 30, 2025 -23.79%
Mar 31, 2025 -20.28%
Dec 31, 2024 -20.39%
API Access

BioAge Labs Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BIOA&period=max&api_key=YOUR_API_KEY